availability string | days_in_shortage string | derived_fields list | dosage_form string | generic_name string | id string | initial_posting_date string | manufacturer_name string | package_ndc string | source string | source_quote string | status string | therapeutic_category string | update_date string | url string | verified_fields list | related_info string | shortage_reason string |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Available | 1750 | [
"days_in_shortage"
] | Injection | Methylprednisolone Acetate Injection | pfizer-inc-methylprednisolone-acetate-injection-0009-0274-01 | 12/15/2021 | Pfizer Inc. | 0009-0274-01 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Methylprednisolone%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "12/15/2021", "package_ndc": "0009-0274-01", "generic_name": "Methylprednisolone Acetate Injection", "contact_info": "844-646-4398", "availability": "Available" | Current | Rheumatology | 09/21/2026 | https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-methylprednisolone-acetate-injection-0009-0274-01/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 1750 | [
"days_in_shortage"
] | Injection | Methylprednisolone Acetate Injection | pfizer-inc-methylprednisolone-acetate-injection-0009-0280-02 | 12/15/2021 | Pfizer Inc. | 0009-0280-02 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Methylprednisolone%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "12/15/2021", "package_ndc": "0009-0280-02", "generic_name": "Methylprednisolone Acetate Injection", "contact_info": "844-646-4398", "availability": "Available" | Current | Rheumatology | 09/21/2026 | https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-methylprednisolone-acetate-injection-0009-0280-02/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Limited Availability | 1750 | [
"days_in_shortage"
] | Injection | Methylprednisolone Acetate Injection | pfizer-inc-methylprednisolone-acetate-injection-0009-0280-03 | 12/15/2021 | Pfizer Inc. | 0009-0280-03 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Methylprednisolone%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "12/15/2021", "package_ndc": "0009-0280-03", "generic_name": "Methylprednisolone Acetate Injection", "contact_info": "844-646-4398", "availability": "Limited Availability", "related_info": "Limited Supply Available. Next Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Ma... | Current | Rheumatology | 09/21/2026 | https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-methylprednisolone-acetate-injection-0009-0280-03/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Limited Supply Available. Next Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay | Other |
Available | 1750 | [
"days_in_shortage"
] | Injection | Methylprednisolone Acetate Injection | pfizer-inc-methylprednisolone-acetate-injection-0009-0280-51 | 12/15/2021 | Pfizer Inc. | 0009-0280-51 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Methylprednisolone%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "12/15/2021", "package_ndc": "0009-0280-51", "generic_name": "Methylprednisolone Acetate Injection", "contact_info": "844-646-4398", "availability": "Available" | Current | Rheumatology | 09/21/2026 | https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-methylprednisolone-acetate-injection-0009-0280-51/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 1750 | [
"days_in_shortage"
] | Injection | Methylprednisolone Acetate Injection | pfizer-inc-methylprednisolone-acetate-injection-0009-0280-52 | 12/15/2021 | Pfizer Inc. | 0009-0280-52 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Methylprednisolone%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "12/15/2021", "package_ndc": "0009-0280-52", "generic_name": "Methylprednisolone Acetate Injection", "contact_info": "844-646-4398", "availability": "Available" | Current | Rheumatology | 09/21/2026 | https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-methylprednisolone-acetate-injection-0009-0280-52/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 1750 | [
"days_in_shortage"
] | Injection | Methylprednisolone Acetate Injection | pfizer-inc-methylprednisolone-acetate-injection-0009-0306-02 | 12/15/2021 | Pfizer Inc. | 0009-0306-02 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Methylprednisolone%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "12/15/2021", "package_ndc": "0009-0306-02", "generic_name": "Methylprednisolone Acetate Injection", "contact_info": "844-646-4398", "availability": "Available" | Current | Rheumatology | 09/21/2026 | https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-methylprednisolone-acetate-injection-0009-0306-02/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 1750 | [
"days_in_shortage"
] | Injection | Methylprednisolone Acetate Injection | pfizer-inc-methylprednisolone-acetate-injection-0009-0306-12 | 12/15/2021 | Pfizer Inc. | 0009-0306-12 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Methylprednisolone%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "12/15/2021", "package_ndc": "0009-0306-12", "generic_name": "Methylprednisolone Acetate Injection", "contact_info": "844-646-4398", "availability": "Available" | Current | Rheumatology | 09/21/2026 | https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-methylprednisolone-acetate-injection-0009-0306-12/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 1289 | [
"days_in_shortage"
] | Injection | Clindamycin Phosphate Injection | pfizer-inc-clindamycin-phosphate-injection-0009-0775-26 | 03/21/2023 | Pfizer Inc. | 0009-0775-26 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Clindamycin%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "03/21/2023", "package_ndc": "0009-0775-26", "generic_name": "Clindamycin Phosphate Injection", "related_info_link": "https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Clindamycin%20Phosphate%20Injection&st=d", "contact_info": "800-533-4535", "availability":... | Current | Anti-Infective | 09/21/2026 | https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-clindamycin-phosphate-injection-0009-0775-26/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Unavailable | 1289 | [
"days_in_shortage"
] | Injection | Clindamycin Phosphate Injection | pfizer-inc-clindamycin-phosphate-injection-0009-0870-26 | 03/21/2023 | Pfizer Inc. | 0009-0870-26 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Clindamycin%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "03/21/2023", "package_ndc": "0009-0870-26", "generic_name": "Clindamycin Phosphate Injection", "related_info_link": "https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Clindamycin%20Phosphate%20Injection&st=d", "contact_info": "800-533-4535", "availability":... | Current | Anti-Infective | 09/21/2026 | https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-clindamycin-phosphate-injection-0009-0870-26/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Next Delivery and Estimated Recovery: December 2028 | Demand increase for the drug |
Available | 1289 | [
"days_in_shortage"
] | Injection | Clindamycin Phosphate Injection | pfizer-inc-clindamycin-phosphate-injection-0009-0902-18 | 03/21/2023 | Pfizer Inc. | 0009-0902-18 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Clindamycin%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "03/21/2023", "package_ndc": "0009-0902-18", "generic_name": "Clindamycin Phosphate Injection", "related_info_link": "https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Clindamycin%20Phosphate%20Injection&st=d", "contact_info": "800-533-4535", "availability":... | Current | Anti-Infective | 09/21/2026 | https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-clindamycin-phosphate-injection-0009-0902-18/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Limited Availability | 1750 | [
"days_in_shortage"
] | Injection | Methylprednisolone Acetate Injection | pfizer-inc-methylprednisolone-acetate-injection-0009-3073-01 | 12/15/2021 | Pfizer Inc. | 0009-3073-01 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Methylprednisolone%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "12/15/2021", "package_ndc": "0009-3073-01", "generic_name": "Methylprednisolone Acetate Injection", "contact_info": "844-646-4398", "availability": "Limited Availability", "related_info": "Limited Supply Available. Next Delivery: October 2026; Estimated Recovery: December 2026" | Current | Rheumatology | 09/21/2026 | https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-methylprednisolone-acetate-injection-0009-3073-01/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Limited Supply Available. Next Delivery: October 2026; Estimated Recovery: December 2026 | Demand increase for the drug |
Limited Availability | 1750 | [
"days_in_shortage"
] | Injection | Methylprednisolone Acetate Injection | pfizer-inc-methylprednisolone-acetate-injection-0009-3073-03 | 12/15/2021 | Pfizer Inc. | 0009-3073-03 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Methylprednisolone%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "12/15/2021", "package_ndc": "0009-3073-03", "generic_name": "Methylprednisolone Acetate Injection", "contact_info": "844-646-4398", "availability": "Limited Availability", "related_info": "Limited Supply Available. Next Delivery: September 2026; Estimated Recovery: December 2026; Shortage per M... | Current | Rheumatology | 09/21/2026 | https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-methylprednisolone-acetate-injection-0009-3073-03/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Limited Supply Available. Next Delivery: September 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay | Other |
Unavailable | 1750 | [
"days_in_shortage"
] | Injection | Methylprednisolone Acetate Injection | pfizer-inc-methylprednisolone-acetate-injection-0009-3073-22 | 12/15/2021 | Pfizer Inc. | 0009-3073-22 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Methylprednisolone%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "12/15/2021", "package_ndc": "0009-3073-22", "generic_name": "Methylprednisolone Acetate Injection", "contact_info": "844-646-4398", "availability": "Unavailable", "related_info": "Next Delivery: October 2026; Estimated Recovery: December 2026" | Current | Rheumatology | 09/21/2026 | https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-methylprednisolone-acetate-injection-0009-3073-22/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Next Delivery: October 2026; Estimated Recovery: December 2026 | Demand increase for the drug |
Unavailable | 1750 | [
"days_in_shortage"
] | Injection | Methylprednisolone Acetate Injection | pfizer-inc-methylprednisolone-acetate-injection-0009-3073-23 | 12/15/2021 | Pfizer Inc. | 0009-3073-23 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Methylprednisolone%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "12/15/2021", "package_ndc": "0009-3073-23", "generic_name": "Methylprednisolone Acetate Injection", "contact_info": "844-646-4398", "availability": "Unavailable", "related_info": "Next Delivery: October 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay" | Current | Rheumatology | 09/21/2026 | https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-methylprednisolone-acetate-injection-0009-3073-23/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Next Delivery: October 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay | Other |
Limited Availability | 1750 | [
"days_in_shortage"
] | Injection | Methylprednisolone Acetate Injection | pfizer-inc-methylprednisolone-acetate-injection-0009-3475-01 | 12/15/2021 | Pfizer Inc. | 0009-3475-01 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Methylprednisolone%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "12/15/2021", "package_ndc": "0009-3475-01", "generic_name": "Methylprednisolone Acetate Injection", "contact_info": "844-646-4398", "availability": "Limited Availability", "related_info": "Limited Supply Available. Next Delivery and Estimated Recovery: December 2026" | Current | Rheumatology | 09/21/2026 | https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-methylprednisolone-acetate-injection-0009-3475-01/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Limited Supply Available. Next Delivery and Estimated Recovery: December 2026 | Demand increase for the drug |
Limited Availability | 1750 | [
"days_in_shortage"
] | Injection | Methylprednisolone Acetate Injection | pfizer-inc-methylprednisolone-acetate-injection-0009-3475-03 | 12/15/2021 | Pfizer Inc. | 0009-3475-03 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Methylprednisolone%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "12/15/2021", "package_ndc": "0009-3475-03", "generic_name": "Methylprednisolone Acetate Injection", "contact_info": "844-646-4398", "availability": "Limited Availability", "related_info": "Limited Supply Available. Next Delivery: September 2026; Estimated Recovery: March 2027; Shortage per Manu... | Current | Rheumatology | 09/21/2026 | https://referencesource.org/drug-shortage-duration-tracker/pfizer-inc-methylprednisolone-acetate-injection-0009-3475-03/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Limited Supply Available. Next Delivery: September 2026; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay | Other |
Available | 1062 | [
"days_in_shortage"
] | Concentrate | Cromolyn Sodium Concentrate | mylan-specialty-a-viatris-company-cromolyn-sodium-concentrate-0037-0678-96 | 11/03/2023 | Mylan Specialty, a Viatris Company | 0037-0678-96 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Mylan%20Specialty,%20a%20Viatris%20Company%22+AND+generic_name%3A%22Cromolyn%20Sodium%20Concentrate%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "11/03/2023", "package_ndc": "0037-0678-96", "generic_name": "Cromolyn Sodium Concentrate", "contact_info": "(800) 796-9526", "availability": "Available" | Current | Pulmonary/Allergy | 09/17/2026 | https://referencesource.org/drug-shortage-duration-tracker/mylan-specialty-a-viatris-company-cromolyn-sodium-concentrate-0037-0678-96/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Unavailable | 2028 | [
"days_in_shortage"
] | Spray | Desmopressin Acetate Spray | ferring-desmopressin-acetate-spray-0053-6871-00 | 03/12/2021 | Ferring | 0053-6871-00 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Ferring%22+AND+generic_name%3A%22Desmopressin%20Acetate%20Spray%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "03/12/2021", "package_ndc": "0053-6871-00", "generic_name": "Desmopressin Acetate Spray", "contact_info": "888-337-7464", "availability": "Unavailable", "related_info": "Estimated recovery: TBD" | Current | Hematology | 05/01/2026 | https://referencesource.org/drug-shortage-duration-tracker/ferring-desmopressin-acetate-spray-0053-6871-00/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Estimated recovery: TBD | Requirements related to complying with good manufacturing practices |
Limited Availability | 1174 | [
"days_in_shortage"
] | Capsule | Lisdexamfetamine Dimesylate Capsule | hikma-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-capsule-0054-0370-25 | 07/14/2023 | Hikma Pharmaceuticals USA, Inc. | 0054-0370-25 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "07/14/2023", "package_ndc": "0054-0370-25", "generic_name": "Lisdexamfetamine Dimesylate Capsule", "contact_info": "800-631-2174", "availability": "Limited Availability", "related_info": "Available on allocation" | Current | Psychiatry | 09/18/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-capsule-0054-0370-25/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Available on allocation | Shortage of an active ingredient |
Limited Availability | 1174 | [
"days_in_shortage"
] | Capsule | Lisdexamfetamine Dimesylate Capsule | hikma-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-capsule-0054-0371-25 | 07/14/2023 | Hikma Pharmaceuticals USA, Inc. | 0054-0371-25 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "07/14/2023", "package_ndc": "0054-0371-25", "generic_name": "Lisdexamfetamine Dimesylate Capsule", "contact_info": "800-631-2174", "availability": "Limited Availability", "related_info": "Available on allocation" | Current | Psychiatry | 09/18/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-capsule-0054-0371-25/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Available on allocation | Shortage of an active ingredient |
Limited Availability | 1174 | [
"days_in_shortage"
] | Capsule | Lisdexamfetamine Dimesylate Capsule | hikma-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-capsule-0054-0372-25 | 07/14/2023 | Hikma Pharmaceuticals USA, Inc. | 0054-0372-25 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "07/14/2023", "package_ndc": "0054-0372-25", "generic_name": "Lisdexamfetamine Dimesylate Capsule", "contact_info": "800-631-2174", "availability": "Limited Availability", "related_info": "Available on allocation" | Current | Psychiatry | 09/18/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-capsule-0054-0372-25/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Available on allocation | Shortage of an active ingredient |
Limited Availability | 1174 | [
"days_in_shortage"
] | Capsule | Lisdexamfetamine Dimesylate Capsule | hikma-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-capsule-0054-0373-25 | 07/14/2023 | Hikma Pharmaceuticals USA, Inc. | 0054-0373-25 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "07/14/2023", "package_ndc": "0054-0373-25", "generic_name": "Lisdexamfetamine Dimesylate Capsule", "contact_info": "800-631-2174", "availability": "Limited Availability", "related_info": "Available on allocation" | Current | Psychiatry | 09/18/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-capsule-0054-0373-25/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Available on allocation | Shortage of an active ingredient |
Limited Availability | 1174 | [
"days_in_shortage"
] | Capsule | Lisdexamfetamine Dimesylate Capsule | hikma-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-capsule-0054-0374-25 | 07/14/2023 | Hikma Pharmaceuticals USA, Inc. | 0054-0374-25 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "07/14/2023", "package_ndc": "0054-0374-25", "generic_name": "Lisdexamfetamine Dimesylate Capsule", "contact_info": "800-631-2174", "availability": "Limited Availability", "related_info": "Available on allocation" | Current | Psychiatry | 09/18/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-capsule-0054-0374-25/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Available on allocation | Shortage of an active ingredient |
Limited Availability | 1174 | [
"days_in_shortage"
] | Capsule | Lisdexamfetamine Dimesylate Capsule | hikma-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-capsule-0054-0375-25 | 07/14/2023 | Hikma Pharmaceuticals USA, Inc. | 0054-0375-25 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "07/14/2023", "package_ndc": "0054-0375-25", "generic_name": "Lisdexamfetamine Dimesylate Capsule", "contact_info": "800-631-2174", "availability": "Limited Availability", "related_info": "Available on allocation" | Current | Psychiatry | 09/18/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-capsule-0054-0375-25/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Available on allocation | Shortage of an active ingredient |
Limited Availability | 1174 | [
"days_in_shortage"
] | Capsule | Lisdexamfetamine Dimesylate Capsule | hikma-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-capsule-0054-0660-25 | 07/14/2023 | Hikma Pharmaceuticals USA, Inc. | 0054-0660-25 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "07/14/2023", "package_ndc": "0054-0660-25", "generic_name": "Lisdexamfetamine Dimesylate Capsule", "contact_info": "800-631-2174", "availability": "Limited Availability", "related_info": "Available on allocation" | Current | Psychiatry | 05/12/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-lisdexamfetamine-dimesylate-capsule-0054-0660-25/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Available on allocation | Shortage of an active ingredient |
Available | 183 | [
"days_in_shortage"
] | Oral Solution | Furosemide Oral Solution | hikma-pharmaceuticals-usa-inc-furosemide-oral-solution-0054-3294-46 | 03/31/2026 | Hikma Pharmaceuticals USA, Inc. | 0054-3294-46 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Furosemide%20Oral%20Solution%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "03/31/2026", "package_ndc": "0054-3294-46", "generic_name": "Furosemide Oral Solution", "contact_info": "800-631-2174", "availability": "Available" | Current | Cardiovascular | 09/18/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-furosemide-oral-solution-0054-3294-46/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | null | Shortage of an inactive ingredient component |
Limited Availability | 183 | [
"days_in_shortage"
] | Oral Solution | Furosemide Oral Solution | hikma-pharmaceuticals-usa-inc-furosemide-oral-solution-0054-3294-50 | 03/31/2026 | Hikma Pharmaceuticals USA, Inc. | 0054-3294-50 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Furosemide%20Oral%20Solution%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "03/31/2026", "package_ndc": "0054-3294-50", "generic_name": "Furosemide Oral Solution", "contact_info": "800-631-2174", "availability": "Limited Availability", "related_info": "Available on allocation" | Current | Cardiovascular | 09/18/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-furosemide-oral-solution-0054-3294-50/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Available on allocation | Shortage of an inactive ingredient component |
Available | 183 | [
"days_in_shortage"
] | Oral Solution | Furosemide Oral Solution | hikma-pharmaceuticals-usa-inc-furosemide-oral-solution-0054-3298-63 | 03/31/2026 | Hikma Pharmaceuticals USA, Inc. | 0054-3298-63 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Furosemide%20Oral%20Solution%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "03/31/2026", "package_ndc": "0054-3298-63", "generic_name": "Furosemide Oral Solution", "contact_info": "800-631-2174", "availability": "Available" | Current | Cardiovascular | 09/18/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-furosemide-oral-solution-0054-3298-63/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | null | Shortage of an inactive ingredient component |
Unavailable | 2051 | [
"days_in_shortage"
] | Injection | Rifampin Injection | sanofi-aventis-u-s-llc-rifampin-injection-0068-0597-01 | 02/17/2021 | Sanofi-Aventis U.S. LLC | 0068-0597-01 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sanofi-Aventis%20U.S.%20LLC%22+AND+generic_name%3A%22Rifampin%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "02/17/2021", "package_ndc": "0068-0597-01", "generic_name": "Rifampin Injection", "related_info_link": "https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Rifampin%20Injection&st=d", "contact_info": "800-633-1610", "availability": "Unavailable", "related_inf... | Current | Anti-Infective | 09/18/2026 | https://referencesource.org/drug-shortage-duration-tracker/sanofi-aventis-u-s-llc-rifampin-injection-0068-0597-01/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Discontinuation of the manufacture of the drug | Discontinuation of the manufacture of the drug |
Available | 1300 | [
"days_in_shortage"
] | Tablet | Clonazepam Tablet | teva-pharmaceuticals-usa-inc-clonazepam-tablet-0093-0832-01 | 03/10/2023 | Teva Pharmaceuticals USA, Inc. | 0093-0832-01 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "03/10/2023", "package_ndc": "0093-0832-01", "generic_name": "Clonazepam Tablet", "contact_info": "800-545-8800", "availability": "Available" | Current | Neurology | 09/15/2026 | https://referencesource.org/drug-shortage-duration-tracker/teva-pharmaceuticals-usa-inc-clonazepam-tablet-0093-0832-01/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 1300 | [
"days_in_shortage"
] | Tablet | Clonazepam Tablet | teva-pharmaceuticals-usa-inc-clonazepam-tablet-0093-0832-05 | 03/10/2023 | Teva Pharmaceuticals USA, Inc. | 0093-0832-05 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "03/10/2023", "package_ndc": "0093-0832-05", "generic_name": "Clonazepam Tablet", "contact_info": "800-545-8800", "availability": "Available" | Current | Neurology | 09/15/2026 | https://referencesource.org/drug-shortage-duration-tracker/teva-pharmaceuticals-usa-inc-clonazepam-tablet-0093-0832-05/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Limited Availability | 1300 | [
"days_in_shortage"
] | Tablet | Clonazepam Tablet | teva-pharmaceuticals-usa-inc-clonazepam-tablet-0093-3212-01 | 03/10/2023 | Teva Pharmaceuticals USA, Inc. | 0093-3212-01 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "03/10/2023", "package_ndc": "0093-3212-01", "generic_name": "Clonazepam Tablet", "contact_info": "800-545-8800", "availability": "Limited Availability", "related_info": "Estimated supply: August 2026" | Current | Neurology | 08/17/2026 | https://referencesource.org/drug-shortage-duration-tracker/teva-pharmaceuticals-usa-inc-clonazepam-tablet-0093-3212-01/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Estimated supply: August 2026 | Other |
Available | 1300 | [
"days_in_shortage"
] | Tablet | Clonazepam Tablet | teva-pharmaceuticals-usa-inc-clonazepam-tablet-0093-3212-05 | 03/10/2023 | Teva Pharmaceuticals USA, Inc. | 0093-3212-05 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "03/10/2023", "package_ndc": "0093-3212-05", "generic_name": "Clonazepam Tablet", "contact_info": "800-545-8800", "availability": "Available" | Current | Neurology | 09/15/2026 | https://referencesource.org/drug-shortage-duration-tracker/teva-pharmaceuticals-usa-inc-clonazepam-tablet-0093-3212-05/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 1300 | [
"days_in_shortage"
] | Tablet | Clonazepam Tablet | teva-pharmaceuticals-usa-inc-clonazepam-tablet-0093-3213-01 | 03/10/2023 | Teva Pharmaceuticals USA, Inc. | 0093-3213-01 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "03/10/2023", "package_ndc": "0093-3213-01", "generic_name": "Clonazepam Tablet", "contact_info": "800-545-8800", "availability": "Available" | Current | Neurology | 09/15/2026 | https://referencesource.org/drug-shortage-duration-tracker/teva-pharmaceuticals-usa-inc-clonazepam-tablet-0093-3213-01/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 1300 | [
"days_in_shortage"
] | Tablet | Clonazepam Tablet | teva-pharmaceuticals-usa-inc-clonazepam-tablet-0093-3213-05 | 03/10/2023 | Teva Pharmaceuticals USA, Inc. | 0093-3213-05 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "03/10/2023", "package_ndc": "0093-3213-05", "generic_name": "Clonazepam Tablet", "contact_info": "800-545-8800", "availability": "Available" | Current | Neurology | 09/15/2026 | https://referencesource.org/drug-shortage-duration-tracker/teva-pharmaceuticals-usa-inc-clonazepam-tablet-0093-3213-05/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 1170 | [
"days_in_shortage"
] | Injection | Liraglutide Injection | hikma-pharmaceuticals-usa-inc-liraglutide-injection-0143-9144-02 | 07/18/2023 | Hikma Pharmaceuticals USA, Inc. | 0143-9144-02 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Liraglutide%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "07/18/2023", "package_ndc": "0143-9144-02", "generic_name": "Liraglutide Injection", "contact_info": "800-631-2174", "availability": "Available" | Current | Endocrinology/Metabolism | 09/18/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-liraglutide-injection-0143-9144-02/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 1170 | [
"days_in_shortage"
] | Injection | Liraglutide Injection | hikma-pharmaceuticals-usa-inc-liraglutide-injection-0143-9144-03 | 07/18/2023 | Hikma Pharmaceuticals USA, Inc. | 0143-9144-03 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Liraglutide%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "07/18/2023", "package_ndc": "0143-9144-03", "generic_name": "Liraglutide Injection", "contact_info": "800-631-2174", "availability": "Available" | Current | Endocrinology/Metabolism | 09/18/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-liraglutide-injection-0143-9144-03/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 1323 | [
"days_in_shortage"
] | Injection | Rocuronium Bromide Injection | hikma-pharmaceuticals-usa-inc-rocuronium-bromide-injection-0143-9250-10 | 02/15/2023 | Hikma Pharmaceuticals USA, Inc. | 0143-9250-10 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Rocuronium%20Bromide%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "02/15/2023", "package_ndc": "0143-9250-10", "generic_name": "Rocuronium Bromide Injection", "contact_info": "800-631-2174", "availability": "Available", "related_info": "Additional lots will be available. Product will be made available as it is released." | Current | Anesthesia | 09/18/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-rocuronium-bromide-injection-0143-9250-10/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"status",
"therapeutic_category",
"update_date"
] | Additional lots will be available. Product will be made available as it is released. | null |
Available | 1323 | [
"days_in_shortage"
] | Injection | Rocuronium Bromide Injection | hikma-pharmaceuticals-usa-inc-rocuronium-bromide-injection-0143-9251-10 | 02/15/2023 | Hikma Pharmaceuticals USA, Inc. | 0143-9251-10 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Rocuronium%20Bromide%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "02/15/2023", "package_ndc": "0143-9251-10", "generic_name": "Rocuronium Bromide Injection", "contact_info": "800-631-2174", "availability": "Available", "related_info": "Additional lots will be available. Product will be made available as it is released." | Current | Anesthesia | 09/18/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-rocuronium-bromide-injection-0143-9251-10/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"status",
"therapeutic_category",
"update_date"
] | Additional lots will be available. Product will be made available as it is released. | null |
Unavailable | 3250 | [
"days_in_shortage"
] | Injection | Dopamine Hydrochloride Injection | hikma-pharmaceuticals-usa-inc-dopamine-hydrochloride-injection-0143-9252-25 | 11/06/2017 | Hikma Pharmaceuticals USA, Inc. | 0143-9252-25 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Dopamine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "11/06/2017", "package_ndc": "0143-9252-25", "generic_name": "Dopamine Hydrochloride Injection", "contact_info": "800-631-2174", "availability": "Unavailable", "related_info": "Product temporarily on backorder. Additional lots will be available in the February 2027 timeframe." | Current | Cardiovascular | 09/18/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-dopamine-hydrochloride-injection-0143-9252-25/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Product temporarily on backorder. Additional lots will be available in the February 2027 timeframe. | Demand increase for the drug |
Unavailable | 3250 | [
"days_in_shortage"
] | Injection | Dopamine Hydrochloride Injection | hikma-pharmaceuticals-usa-inc-dopamine-hydrochloride-injection-0143-9254-25 | 11/06/2017 | Hikma Pharmaceuticals USA, Inc. | 0143-9254-25 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Dopamine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "11/06/2017", "package_ndc": "0143-9254-25", "generic_name": "Dopamine Hydrochloride Injection", "contact_info": "800-631-2174", "availability": "Unavailable", "related_info": "Additional lots will be available in the October 2026 timeframe. Product will be made available as it is released." | Current | Cardiovascular | 09/18/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-dopamine-hydrochloride-injection-0143-9254-25/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Additional lots will be available in the October 2026 timeframe. Product will be made available as it is released. | Demand increase for the drug |
Available | 1456 | [
"days_in_shortage"
] | Injection | Etomidate Injection | hikma-pharmaceuticals-usa-inc-etomidate-injection-0143-9310-10 | 10/05/2022 | Hikma Pharmaceuticals USA, Inc. | 0143-9310-10 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Etomidate%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "10/05/2022", "package_ndc": "0143-9310-10", "generic_name": "Etomidate Injection", "contact_info": "800-631-2174", "availability": "Available", "related_info": "Novaplus label" | Current | Anesthesia | 09/18/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-etomidate-injection-0143-9310-10/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"status",
"therapeutic_category",
"update_date"
] | Novaplus label | null |
Available | 1456 | [
"days_in_shortage"
] | Injection | Etomidate Injection | hikma-pharmaceuticals-usa-inc-etomidate-injection-0143-9311-10 | 10/05/2022 | Hikma Pharmaceuticals USA, Inc. | 0143-9311-10 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Etomidate%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "10/05/2022", "package_ndc": "0143-9311-10", "generic_name": "Etomidate Injection", "contact_info": "800-631-2174", "availability": "Available", "related_info": "Novaplus label" | Current | Anesthesia | 09/18/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-etomidate-injection-0143-9311-10/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"status",
"therapeutic_category",
"update_date"
] | Novaplus label | null |
Unavailable | 1555 | [
"days_in_shortage"
] | Injection | Remifentanil Hydrochloride Injection | hikma-pharmaceuticals-usa-inc-remifentanil-hydrochloride-injection-0143-9391-10 | 06/28/2022 | Hikma Pharmaceuticals USA, Inc. | 0143-9391-10 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Remifentanil%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "06/28/2022", "package_ndc": "0143-9391-10", "generic_name": "Remifentanil Hydrochloride Injection", "contact_info": "800-631-2174", "availability": "Unavailable", "related_info": "Estimated recovery: TBD" | Current | Analgesia/Addiction | 09/18/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-remifentanil-hydrochloride-injection-0143-9391-10/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Estimated recovery: TBD | Demand increase for the drug |
Unavailable | 1555 | [
"days_in_shortage"
] | Injection | Remifentanil Hydrochloride Injection | hikma-pharmaceuticals-usa-inc-remifentanil-hydrochloride-injection-0143-9392-10 | 06/28/2022 | Hikma Pharmaceuticals USA, Inc. | 0143-9392-10 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Remifentanil%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "06/28/2022", "package_ndc": "0143-9392-10", "generic_name": "Remifentanil Hydrochloride Injection", "contact_info": "800-631-2174", "availability": "Unavailable", "related_info": "Estimated recovery: TBD" | Current | Analgesia/Addiction | 09/18/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-remifentanil-hydrochloride-injection-0143-9392-10/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Estimated recovery: TBD | Demand increase for the drug |
Available | 1555 | [
"days_in_shortage"
] | Injection | Remifentanil Hydrochloride Injection | hikma-pharmaceuticals-usa-inc-remifentanil-hydrochloride-injection-0143-9393-10 | 06/28/2022 | Hikma Pharmaceuticals USA, Inc. | 0143-9393-10 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Remifentanil%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "06/28/2022", "package_ndc": "0143-9393-10", "generic_name": "Remifentanil Hydrochloride Injection", "contact_info": "800-631-2174", "availability": "Available", "related_info": "Additional lots will be available. Product will be made available as it is released." | Current | Analgesia/Addiction | 09/18/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-remifentanil-hydrochloride-injection-0143-9393-10/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"status",
"therapeutic_category",
"update_date"
] | Additional lots will be available. Product will be made available as it is released. | null |
Available | 1456 | [
"days_in_shortage"
] | Injection | Etomidate Injection | hikma-pharmaceuticals-usa-inc-etomidate-injection-0143-9506-10 | 10/05/2022 | Hikma Pharmaceuticals USA, Inc. | 0143-9506-10 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Etomidate%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "10/05/2022", "package_ndc": "0143-9506-10", "generic_name": "Etomidate Injection", "contact_info": "800-631-2174", "availability": "Available", "related_info": "Additional product will be made available as it is released." | Current | Anesthesia | 09/18/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-etomidate-injection-0143-9506-10/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"status",
"therapeutic_category",
"update_date"
] | Additional product will be made available as it is released. | null |
Available | 1456 | [
"days_in_shortage"
] | Injection | Etomidate Injection | hikma-pharmaceuticals-usa-inc-etomidate-injection-0143-9507-10 | 10/05/2022 | Hikma Pharmaceuticals USA, Inc. | 0143-9507-10 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Etomidate%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "10/05/2022", "package_ndc": "0143-9507-10", "generic_name": "Etomidate Injection", "contact_info": "800-631-2174", "availability": "Available", "related_info": "Additional product will be made available as it is released." | Current | Anesthesia | 09/18/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-etomidate-injection-0143-9507-10/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"status",
"therapeutic_category",
"update_date"
] | Additional product will be made available as it is released. | null |
Unavailable | 1297 | [
"days_in_shortage"
] | Injection | Methotrexate Sodium Injection | hikma-pharmaceuticals-usa-inc-methotrexate-sodium-injection-0143-9519-10 | 03/13/2023 | Hikma Pharmaceuticals USA, Inc. | 0143-9519-10 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Methotrexate%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "03/13/2023", "package_ndc": "0143-9519-10", "generic_name": "Methotrexate Sodium Injection", "contact_info": "800-631-2174", "availability": "Unavailable", "related_info": "Additional lots will be available in the October 2026 timeframe. Product will be made available as it is released." | Current | Rheumatology | 09/18/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-methotrexate-sodium-injection-0143-9519-10/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Additional lots will be available in the October 2026 timeframe. Product will be made available as it is released. | Demand increase for the drug |
Unavailable | 110 | [
"days_in_shortage"
] | Injection | Ifosfamide Injection | hikma-pharmaceuticals-usa-inc-ifosfamide-injection-0143-9530-01 | 06/12/2026 | Hikma Pharmaceuticals USA, Inc. | 0143-9530-01 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Ifosfamide%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "06/12/2026", "package_ndc": "0143-9530-01", "generic_name": "Ifosfamide Injection", "contact_info": "800-631-2174", "availability": "Unavailable", "related_info": "Additional lots will be available in the September 2026 timeframe. Product will be made available as it is released." | Current | Oncology | 09/18/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-ifosfamide-injection-0143-9530-01/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Additional lots will be available in the September 2026 timeframe. Product will be made available as it is released. | Demand increase for the drug |
Unavailable | 110 | [
"days_in_shortage"
] | Injection | Ifosfamide Injection | hikma-pharmaceuticals-usa-inc-ifosfamide-injection-0143-9531-01 | 06/12/2026 | Hikma Pharmaceuticals USA, Inc. | 0143-9531-01 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Ifosfamide%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "06/12/2026", "package_ndc": "0143-9531-01", "generic_name": "Ifosfamide Injection", "contact_info": "800-631-2174", "availability": "Unavailable", "related_info": "Additional lots will be available in the September 2026 timeframe. Product will be made available as it is released." | Current | Oncology | 09/18/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-ifosfamide-injection-0143-9531-01/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Additional lots will be available in the September 2026 timeframe. Product will be made available as it is released. | Demand increase for the drug |
Unavailable | 2364 | [
"days_in_shortage"
] | Injection | Dexmedetomidine Hydrochloride Injection | hikma-pharmaceuticals-usa-inc-dexmedetomidine-hydrochloride-injection-0143-9532-25 | 04/10/2020 | Hikma Pharmaceuticals USA, Inc. | 0143-9532-25 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "04/10/2020", "package_ndc": "0143-9532-25", "generic_name": "Dexmedetomidine Hydrochloride Injection", "contact_info": "800-631-2174", "availability": "Unavailable", "related_info": "Product temporarily on backorder. Additional lots will be available in the September 2026 timeframe." | Current | Anesthesia | 09/18/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-dexmedetomidine-hydrochloride-injection-0143-9532-25/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Product temporarily on backorder. Additional lots will be available in the September 2026 timeframe. | Demand increase for the drug |
Available | 3031 | [
"days_in_shortage"
] | Injection | Lidocaine Hydrochloride Injection | hikma-pharmaceuticals-usa-inc-lidocaine-hydrochloride-injection-0143-9575-10 | 06/13/2018 | Hikma Pharmaceuticals USA, Inc. | 0143-9575-10 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "06/13/2018", "package_ndc": "0143-9575-10", "generic_name": "Lidocaine Hydrochloride Injection", "contact_info": "800-631-2174", "availability": "Available", "related_info": "Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released." | Current | Anesthesia | 09/18/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-lidocaine-hydrochloride-injection-0143-9575-10/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"status",
"therapeutic_category",
"update_date"
] | Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released. | null |
Available | 3031 | [
"days_in_shortage"
] | Injection | Lidocaine Hydrochloride Injection | hikma-pharmaceuticals-usa-inc-lidocaine-hydrochloride-injection-0143-9577-10 | 06/13/2018 | Hikma Pharmaceuticals USA, Inc. | 0143-9577-10 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "06/13/2018", "package_ndc": "0143-9577-10", "generic_name": "Lidocaine Hydrochloride Injection", "contact_info": "800-631-2174", "availability": "Available", "related_info": "Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released." | Current | Anesthesia | 09/18/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-lidocaine-hydrochloride-injection-0143-9577-10/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"status",
"therapeutic_category",
"update_date"
] | Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released. | null |
Available | 3031 | [
"days_in_shortage"
] | Injection | Lidocaine Hydrochloride Injection | hikma-pharmaceuticals-usa-inc-lidocaine-hydrochloride-injection-0143-9594-25 | 06/13/2018 | Hikma Pharmaceuticals USA, Inc. | 0143-9594-25 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "06/13/2018", "package_ndc": "0143-9594-25", "generic_name": "Lidocaine Hydrochloride Injection", "contact_info": "800-631-2174", "availability": "Available", "related_info": "Additional lots are scheduled to be manufactured. Product will be made available as it is released." | Current | Anesthesia | 09/18/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-lidocaine-hydrochloride-injection-0143-9594-25/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"status",
"therapeutic_category",
"update_date"
] | Additional lots are scheduled to be manufactured. Product will be made available as it is released. | null |
Available | 3031 | [
"days_in_shortage"
] | Injection | Lidocaine Hydrochloride Injection | hikma-pharmaceuticals-usa-inc-lidocaine-hydrochloride-injection-0143-9595-25 | 06/13/2018 | Hikma Pharmaceuticals USA, Inc. | 0143-9595-25 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "06/13/2018", "package_ndc": "0143-9595-25", "generic_name": "Lidocaine Hydrochloride Injection", "contact_info": "800-631-2174", "availability": "Available", "related_info": "Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released." | Current | Anesthesia | 09/18/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-lidocaine-hydrochloride-injection-0143-9595-25/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"status",
"therapeutic_category",
"update_date"
] | Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released. | null |
Available | 2112 | [
"days_in_shortage"
] | Injection | Azacitidine Injection | hikma-pharmaceuticals-usa-inc-azacitidine-injection-0143-9606-01 | 12/18/2020 | Hikma Pharmaceuticals USA, Inc. | 0143-9606-01 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Azacitidine%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "12/18/2020", "package_ndc": "0143-9606-01", "generic_name": "Azacitidine Injection", "contact_info": "1-800-631-2174", "availability": "Available", "related_info": "Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released." | Current | Oncology | 09/18/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-azacitidine-injection-0143-9606-01/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"status",
"therapeutic_category",
"update_date"
] | Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released. | null |
Available | 2100 | [
"days_in_shortage"
] | Injection | Valproate Sodium Injection | hikma-pharmaceuticals-usa-inc-valproate-sodium-injection-0143-9785-10 | 12/30/2020 | Hikma Pharmaceuticals USA, Inc. | 0143-9785-10 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Valproate%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "12/30/2020", "package_ndc": "0143-9785-10", "generic_name": "Valproate Sodium Injection", "contact_info": "800-631-2174", "availability": "Available", "related_info": "Additional lots will be available. Product will be made available as it is released." | Current | Neurology | 09/18/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-valproate-sodium-injection-0143-9785-10/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"status",
"therapeutic_category",
"update_date"
] | Additional lots will be available. Product will be made available as it is released. | null |
Unavailable | 1297 | [
"days_in_shortage"
] | Injection | Methotrexate Sodium Injection | hikma-pharmaceuticals-usa-inc-methotrexate-sodium-injection-0143-9830-01 | 03/13/2023 | Hikma Pharmaceuticals USA, Inc. | 0143-9830-01 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Methotrexate%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "03/13/2023", "package_ndc": "0143-9830-01", "generic_name": "Methotrexate Sodium Injection", "contact_info": "800-631-2174", "availability": "Unavailable", "related_info": "Additional lots will be available in the September 2026 timeframe. Product will be made available as it is released." | Current | Rheumatology | 09/18/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-methotrexate-sodium-injection-0143-9830-01/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Additional lots will be available in the September 2026 timeframe. Product will be made available as it is released. | Demand increase for the drug |
Unavailable | 1065 | [
"days_in_shortage"
] | Injection | Propranolol Hydrochloride Injection | hikma-pharmaceuticals-usa-inc-propranolol-hydrochloride-injection-0143-9872-10 | 10/31/2023 | Hikma Pharmaceuticals USA, Inc. | 0143-9872-10 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Propranolol%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "10/31/2023", "package_ndc": "0143-9872-10", "generic_name": "Propranolol Hydrochloride Injection", "contact_info": "800-631-2174", "availability": "Unavailable", "related_info": "Estimated recovery: TBD" | Current | Cardiovascular | 09/18/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-propranolol-hydrochloride-injection-0143-9872-10/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Estimated recovery: TBD | Shortage of an active ingredient |
Unavailable | 4243 | [
"days_in_shortage"
] | Powder, For Solution | Cefotaxime Sodium Powder, for Solution | hikma-pharmaceuticals-usa-inc-cefotaxime-sodium-powder-for-solution-0143-9930-10 | 02/17/2015 | Hikma Pharmaceuticals USA, Inc. | 0143-9930-10 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Cefotaxime%20Sodium%20Powder,%20for%20Solution%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "02/17/2015", "package_ndc": "0143-9930-10", "generic_name": "Cefotaxime Sodium Powder, for Solution", "contact_info": "800-631-2174", "availability": "Unavailable", "related_info": "Estimated recovery: TBD" | Current | Anti-Infective | 09/18/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-cefotaxime-sodium-powder-for-solution-0143-9930-10/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Estimated recovery: TBD | Demand increase for the drug |
Unavailable | 4243 | [
"days_in_shortage"
] | Powder, For Solution | Cefotaxime Sodium Powder, for Solution | hikma-pharmaceuticals-usa-inc-cefotaxime-sodium-powder-for-solution-0143-9931-25 | 02/17/2015 | Hikma Pharmaceuticals USA, Inc. | 0143-9931-25 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Cefotaxime%20Sodium%20Powder,%20for%20Solution%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "02/17/2015", "package_ndc": "0143-9931-25", "generic_name": "Cefotaxime Sodium Powder, for Solution", "contact_info": "800-631-2174", "availability": "Unavailable", "related_info": "Estimated recovery: TBD" | Current | Anti-Infective | 09/18/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-cefotaxime-sodium-powder-for-solution-0143-9931-25/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Estimated recovery: TBD | Demand increase for the drug |
Unavailable | 4243 | [
"days_in_shortage"
] | Powder, For Solution | Cefotaxime Sodium Powder, for Solution | hikma-pharmaceuticals-usa-inc-cefotaxime-sodium-powder-for-solution-0143-9933-25 | 02/17/2015 | Hikma Pharmaceuticals USA, Inc. | 0143-9933-25 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Cefotaxime%20Sodium%20Powder,%20for%20Solution%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "02/17/2015", "package_ndc": "0143-9933-25", "generic_name": "Cefotaxime Sodium Powder, for Solution", "contact_info": "800-631-2174", "availability": "Unavailable", "related_info": "Estimated recovery: TBD" | Current | Anti-Infective | 09/18/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-cefotaxime-sodium-powder-for-solution-0143-9933-25/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Estimated recovery: TBD | Demand increase for the drug |
Unavailable | 4243 | [
"days_in_shortage"
] | Powder, For Solution | Cefotaxime Sodium Powder, for Solution | hikma-pharmaceuticals-usa-inc-cefotaxime-sodium-powder-for-solution-0143-9935-01 | 02/17/2015 | Hikma Pharmaceuticals USA, Inc. | 0143-9935-01 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Cefotaxime%20Sodium%20Powder,%20for%20Solution%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "02/17/2015", "package_ndc": "0143-9935-01", "generic_name": "Cefotaxime Sodium Powder, for Solution", "contact_info": "800-631-2174", "availability": "Unavailable", "related_info": "Estimated recovery: TBD" | Current | Anti-Infective | 09/18/2026 | https://referencesource.org/drug-shortage-duration-tracker/hikma-pharmaceuticals-usa-inc-cefotaxime-sodium-powder-for-solution-0143-9935-01/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Estimated recovery: TBD | Demand increase for the drug |
Limited Availability | 1170 | [
"days_in_shortage"
] | Injection | Liraglutide Injection | novo-nordisk-inc-liraglutide-injection-0169-2800-15 | 07/18/2023 | Novo Nordisk, Inc. | 0169-2800-15 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Novo%20Nordisk,%20Inc.%22+AND+generic_name%3A%22Liraglutide%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "07/18/2023", "package_ndc": "0169-2800-15", "generic_name": "Liraglutide Injection", "related_info_link": "https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Liraglutide+Injection&st=d", "contact_info": "833-493-4689", "availability": "Limited Availability",... | Current | Endocrinology/Metabolism | 09/22/2026 | https://referencesource.org/drug-shortage-duration-tracker/novo-nordisk-inc-liraglutide-injection-0169-2800-15/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Product will be available until discontinuation in January 2027 | Discontinuation of the manufacture of the drug |
Limited Availability | 1170 | [
"days_in_shortage"
] | Injection | Liraglutide Injection | novo-nordisk-inc-liraglutide-injection-0169-4060-12 | 07/18/2023 | Novo Nordisk, Inc. | 0169-4060-12 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Novo%20Nordisk,%20Inc.%22+AND+generic_name%3A%22Liraglutide%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "07/18/2023", "package_ndc": "0169-4060-12", "generic_name": "Liraglutide Injection", "contact_info": "833-493-4689", "availability": "Limited Availability", "related_info": "Estimated shortage duration: TBD" | Current | Endocrinology/Metabolism | 09/22/2026 | https://referencesource.org/drug-shortage-duration-tracker/novo-nordisk-inc-liraglutide-injection-0169-4060-12/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Estimated shortage duration: TBD | Delay in shipping of the drug |
Limited Availability | 1170 | [
"days_in_shortage"
] | Injection | Liraglutide Injection | novo-nordisk-inc-liraglutide-injection-0169-4060-13 | 07/18/2023 | Novo Nordisk, Inc. | 0169-4060-13 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Novo%20Nordisk,%20Inc.%22+AND+generic_name%3A%22Liraglutide%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "07/18/2023", "package_ndc": "0169-4060-13", "generic_name": "Liraglutide Injection", "contact_info": "833-493-4689", "availability": "Limited Availability", "related_info": "Estimated shortage duration: TBD" | Current | Endocrinology/Metabolism | 09/22/2026 | https://referencesource.org/drug-shortage-duration-tracker/novo-nordisk-inc-liraglutide-injection-0169-4060-13/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Estimated shortage duration: TBD | Delay in shipping of the drug |
Available | 1449 | [
"days_in_shortage"
] | Tablet | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | sandoz-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-0185-0842-01 | 10/12/2022 | Sandoz Inc. | 0185-0842-01 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sandoz%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "10/12/2022", "package_ndc": "0185-0842-01", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "800-525-8747", "availability": "Available" | Current | Psychiatry | 09/18/2026 | https://referencesource.org/drug-shortage-duration-tracker/sandoz-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-0185-0842-01/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 1449 | [
"days_in_shortage"
] | Tablet | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | sandoz-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-0185-0853-01 | 10/12/2022 | Sandoz Inc. | 0185-0853-01 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sandoz%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "10/12/2022", "package_ndc": "0185-0853-01", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "800-525-8747", "availability": "Available" | Current | Psychiatry | 09/18/2026 | https://referencesource.org/drug-shortage-duration-tracker/sandoz-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-0185-0853-01/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 1449 | [
"days_in_shortage"
] | Tablet | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | sandoz-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-0185-2098-01 | 10/12/2022 | Sandoz Inc. | 0185-2098-01 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sandoz%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "10/12/2022", "package_ndc": "0185-2098-01", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "800-525-8747", "availability": "Available" | Current | Psychiatry | 09/18/2026 | https://referencesource.org/drug-shortage-duration-tracker/sandoz-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-0185-2098-01/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 1449 | [
"days_in_shortage"
] | Tablet | Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet | sandoz-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-0185-2099-01 | 10/12/2022 | Sandoz Inc. | 0185-2099-01 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sandoz%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "10/12/2022", "package_ndc": "0185-2099-01", "generic_name": "Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet", "contact_info": "800-525-8747", "availability": "Available" | Current | Psychiatry | 09/18/2026 | https://referencesource.org/drug-shortage-duration-tracker/sandoz-inc-amphetamine-aspartate-monohydrate-amphetamine-sulfate-dextroamphetamine-sacchara-0185-2099-01/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 1689 | [
"days_in_shortage"
] | Injection | Dextrose Monohydrate 5% Injection | b-braun-medical-inc-dextrose-monohydrate-5-injection-0264-1510-31 | 02/14/2022 | B. Braun Medical Inc. | 0264-1510-31 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "02/14/2022", "package_ndc": "0264-1510-31", "generic_name": "Dextrose Monohydrate 5% Injection", "contact_info": "800-227-2862", "availability": "Available" | Current | Endocrinology/Metabolism | 09/22/2026 | https://referencesource.org/drug-shortage-duration-tracker/b-braun-medical-inc-dextrose-monohydrate-5-injection-0264-1510-31/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 1689 | [
"days_in_shortage"
] | Injection | Dextrose Monohydrate 5% Injection | b-braun-medical-inc-dextrose-monohydrate-5-injection-0264-1510-32 | 02/14/2022 | B. Braun Medical Inc. | 0264-1510-32 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "02/14/2022", "package_ndc": "0264-1510-32", "generic_name": "Dextrose Monohydrate 5% Injection", "contact_info": "800-227-2862", "availability": "Available" | Current | Endocrinology/Metabolism | 09/22/2026 | https://referencesource.org/drug-shortage-duration-tracker/b-braun-medical-inc-dextrose-monohydrate-5-injection-0264-1510-32/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 2122 | [
"days_in_shortage"
] | Injection | Amino Acid Injection | b-braun-medical-inc-amino-acid-injection-0264-1933-10 | 12/08/2020 | B. Braun Medical Inc. | 0264-1933-10 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Amino%20Acid%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "12/08/2020", "package_ndc": "0264-1933-10", "generic_name": "Amino Acid Injection", "contact_info": "800-227-2862", "availability": "Available" | Current | Gastroenterology | 09/22/2026 | https://referencesource.org/drug-shortage-duration-tracker/b-braun-medical-inc-amino-acid-injection-0264-1933-10/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 1251 | [
"days_in_shortage"
] | Irrigant | Sterile Water Irrigant | b-braun-medical-inc-sterile-water-irrigant-0264-2101-00 | 04/28/2023 | B. Braun Medical Inc. | 0264-2101-00 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Sterile%20Water%20Irrigant%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "04/28/2023", "package_ndc": "0264-2101-00", "generic_name": "Sterile Water Irrigant", "company_name": "B. Braun Medical Inc.", "contact_info": "800-227-2862", "availability": "Available" | Current | Gastroenterology | 09/22/2026 | https://referencesource.org/drug-shortage-duration-tracker/b-braun-medical-inc-sterile-water-irrigant-0264-2101-00/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 1251 | [
"days_in_shortage"
] | Irrigant | Sterile Water Irrigant | b-braun-medical-inc-sterile-water-irrigant-0264-2101-10 | 04/28/2023 | B. Braun Medical Inc. | 0264-2101-10 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Sterile%20Water%20Irrigant%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "04/28/2023", "package_ndc": "0264-2101-10", "generic_name": "Sterile Water Irrigant", "company_name": "B. Braun Medical Inc.", "contact_info": "800-227-2862", "availability": "Available" | Current | Gastroenterology | 09/22/2026 | https://referencesource.org/drug-shortage-duration-tracker/b-braun-medical-inc-sterile-water-irrigant-0264-2101-10/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 2122 | [
"days_in_shortage"
] | Injection | Amino Acid Injection | b-braun-medical-inc-amino-acid-injection-0264-4500-00 | 12/08/2020 | B. Braun Medical Inc. | 0264-4500-00 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Amino%20Acid%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "12/08/2020", "package_ndc": "0264-4500-00", "generic_name": "Amino Acid Injection", "contact_info": "800-227-2862", "availability": "Available" | Current | Gastroenterology | 09/22/2026 | https://referencesource.org/drug-shortage-duration-tracker/b-braun-medical-inc-amino-acid-injection-0264-4500-00/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 2122 | [
"days_in_shortage"
] | Injection | Amino Acid Injection | b-braun-medical-inc-amino-acid-injection-0264-4500-05 | 12/08/2020 | B. Braun Medical Inc. | 0264-4500-05 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Amino%20Acid%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "12/08/2020", "package_ndc": "0264-4500-05", "generic_name": "Amino Acid Injection", "contact_info": "800-227-2862", "availability": "Available" | Current | Gastroenterology | 09/22/2026 | https://referencesource.org/drug-shortage-duration-tracker/b-braun-medical-inc-amino-acid-injection-0264-4500-05/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 719 | [
"days_in_shortage"
] | Injection | Dextrose Monohydrate 70% Injection | b-braun-medical-inc-dextrose-monohydrate-70-injection-0264-7387-50 | 10/11/2024 | B. Braun Medical Inc. | 0264-7387-50 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Dextrose%20Monohydrate%2070%25%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "10/11/2024", "package_ndc": "0264-7387-50", "generic_name": "Dextrose Monohydrate 70% Injection", "contact_info": "800-227-2862", "availability": "Available" | Current | Endocrinology/Metabolism | 09/22/2026 | https://referencesource.org/drug-shortage-duration-tracker/b-braun-medical-inc-dextrose-monohydrate-70-injection-0264-7387-50/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 1689 | [
"days_in_shortage"
] | Injection | Dextrose Monohydrate 5% Injection | b-braun-medical-inc-dextrose-monohydrate-5-injection-0264-7510-00 | 02/14/2022 | B. Braun Medical Inc. | 0264-7510-00 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "02/14/2022", "package_ndc": "0264-7510-00", "generic_name": "Dextrose Monohydrate 5% Injection", "contact_info": "800-227-2862", "availability": "Available" | Current | Endocrinology/Metabolism | 09/22/2026 | https://referencesource.org/drug-shortage-duration-tracker/b-braun-medical-inc-dextrose-monohydrate-5-injection-0264-7510-00/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 1689 | [
"days_in_shortage"
] | Injection | Dextrose Monohydrate 5% Injection | b-braun-medical-inc-dextrose-monohydrate-5-injection-0264-7510-10 | 02/14/2022 | B. Braun Medical Inc. | 0264-7510-10 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "02/14/2022", "package_ndc": "0264-7510-10", "generic_name": "Dextrose Monohydrate 5% Injection", "contact_info": "800-227-2862", "availability": "Available" | Current | Endocrinology/Metabolism | 09/22/2026 | https://referencesource.org/drug-shortage-duration-tracker/b-braun-medical-inc-dextrose-monohydrate-5-injection-0264-7510-10/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 1689 | [
"days_in_shortage"
] | Injection | Dextrose Monohydrate 5% Injection | b-braun-medical-inc-dextrose-monohydrate-5-injection-0264-7510-20 | 02/14/2022 | B. Braun Medical Inc. | 0264-7510-20 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "02/14/2022", "package_ndc": "0264-7510-20", "generic_name": "Dextrose Monohydrate 5% Injection", "contact_info": "800-227-2862", "availability": "Available" | Current | Endocrinology/Metabolism | 09/22/2026 | https://referencesource.org/drug-shortage-duration-tracker/b-braun-medical-inc-dextrose-monohydrate-5-injection-0264-7510-20/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 1674 | [
"days_in_shortage"
] | Injection | Dextrose Monohydrate 10% Injection | b-braun-medical-inc-dextrose-monohydrate-10-injection-0264-7520-00 | 03/01/2022 | B. Braun Medical Inc. | 0264-7520-00 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Dextrose%20Monohydrate%2010%25%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "03/01/2022", "package_ndc": "0264-7520-00", "generic_name": "Dextrose Monohydrate 10% Injection", "contact_info": "800-227-2862", "availability": "Available" | Current | Endocrinology/Metabolism | 09/22/2026 | https://referencesource.org/drug-shortage-duration-tracker/b-braun-medical-inc-dextrose-monohydrate-10-injection-0264-7520-00/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 1674 | [
"days_in_shortage"
] | Injection | Dextrose Monohydrate 10% Injection | b-braun-medical-inc-dextrose-monohydrate-10-injection-0264-7520-10 | 03/01/2022 | B. Braun Medical Inc. | 0264-7520-10 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Dextrose%20Monohydrate%2010%25%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "03/01/2022", "package_ndc": "0264-7520-10", "generic_name": "Dextrose Monohydrate 10% Injection", "contact_info": "800-227-2862", "availability": "Available" | Current | Endocrinology/Metabolism | 09/22/2026 | https://referencesource.org/drug-shortage-duration-tracker/b-braun-medical-inc-dextrose-monohydrate-10-injection-0264-7520-10/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 1674 | [
"days_in_shortage"
] | Injection | Dextrose Monohydrate 10% Injection | b-braun-medical-inc-dextrose-monohydrate-10-injection-0264-7520-20 | 03/01/2022 | B. Braun Medical Inc. | 0264-7520-20 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Dextrose%20Monohydrate%2010%25%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "03/01/2022", "package_ndc": "0264-7520-20", "generic_name": "Dextrose Monohydrate 10% Injection", "contact_info": "800-227-2862", "availability": "Available" | Current | Endocrinology/Metabolism | 09/22/2026 | https://referencesource.org/drug-shortage-duration-tracker/b-braun-medical-inc-dextrose-monohydrate-10-injection-0264-7520-20/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 3262 | [
"days_in_shortage"
] | Injection | Lidocaine Hydrochloride Injection | b-braun-medical-inc-lidocaine-hydrochloride-injection-0264-9594-10 | 10/25/2017 | B. Braun Medical Inc. | 0264-9594-10 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "10/25/2017", "package_ndc": "0264-9594-10", "generic_name": "Lidocaine Hydrochloride Injection", "contact_info": "800-227-2862", "availability": "Available" | Current | Cardiovascular | 09/22/2026 | https://referencesource.org/drug-shortage-duration-tracker/b-braun-medical-inc-lidocaine-hydrochloride-injection-0264-9594-10/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 3262 | [
"days_in_shortage"
] | Injection | Lidocaine Hydrochloride Injection | b-braun-medical-inc-lidocaine-hydrochloride-injection-0264-9594-20 | 10/25/2017 | B. Braun Medical Inc. | 0264-9594-20 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "10/25/2017", "package_ndc": "0264-9594-20", "generic_name": "Lidocaine Hydrochloride Injection", "contact_info": "800-227-2862", "availability": "Available" | Current | Cardiovascular | 09/22/2026 | https://referencesource.org/drug-shortage-duration-tracker/b-braun-medical-inc-lidocaine-hydrochloride-injection-0264-9594-20/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 3262 | [
"days_in_shortage"
] | Injection | Lidocaine Hydrochloride Injection | b-braun-medical-inc-lidocaine-hydrochloride-injection-0264-9598-20 | 10/25/2017 | B. Braun Medical Inc. | 0264-9598-20 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "10/25/2017", "package_ndc": "0264-9598-20", "generic_name": "Lidocaine Hydrochloride Injection", "contact_info": "800-227-2862", "availability": "Available" | Current | Cardiovascular | 09/22/2026 | https://referencesource.org/drug-shortage-duration-tracker/b-braun-medical-inc-lidocaine-hydrochloride-injection-0264-9598-20/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Limited Availability | 3242 | [
"days_in_shortage"
] | Injection | Heparin Sodium Injection | b-braun-medical-inc-heparin-sodium-injection-0264-9872-00 | 11/14/2017 | B. Braun Medical Inc. | 0264-9872-00 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Heparin%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "11/14/2017", "package_ndc": "0264-9872-00", "generic_name": "Heparin Sodium Injection", "contact_info": "800-227-2862", "availability": "Limited Availability", "related_info": "Estimated recovery: late Q4 2026; Manufacturing delays" | Current | Hematology | 09/22/2026 | https://referencesource.org/drug-shortage-duration-tracker/b-braun-medical-inc-heparin-sodium-injection-0264-9872-00/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Estimated recovery: late Q4 2026; Manufacturing delays | Other |
Limited Availability | 3242 | [
"days_in_shortage"
] | Injection | Heparin Sodium Injection | b-braun-medical-inc-heparin-sodium-injection-0264-9872-10 | 11/14/2017 | B. Braun Medical Inc. | 0264-9872-10 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Heparin%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "11/14/2017", "package_ndc": "0264-9872-10", "generic_name": "Heparin Sodium Injection", "contact_info": "800-227-2862", "availability": "Limited Availability", "related_info": "Estimated recovery: late Q4 2026; Manufacturing delays" | Current | Hematology | 09/22/2026 | https://referencesource.org/drug-shortage-duration-tracker/b-braun-medical-inc-heparin-sodium-injection-0264-9872-10/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Estimated recovery: late Q4 2026; Manufacturing delays | Other |
Available | 1251 | [
"days_in_shortage"
] | Irrigant | Sterile Water Irrigant | baxter-healthcare-sterile-water-irrigant-0338-0004-02 | 04/28/2023 | Baxter Healthcare | 0338-0004-02 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Sterile%20Water%20Irrigant%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "04/28/2023", "package_ndc": "0338-0004-02", "generic_name": "Sterile Water Irrigant", "contact_info": "888-229-0001", "availability": "Available" | Current | Gastroenterology | 09/17/2026 | https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-sterile-water-irrigant-0338-0004-02/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 1251 | [
"days_in_shortage"
] | Irrigant | Sterile Water Irrigant | baxter-healthcare-sterile-water-irrigant-0338-0004-03 | 04/28/2023 | Baxter Healthcare | 0338-0004-03 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Sterile%20Water%20Irrigant%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "04/28/2023", "package_ndc": "0338-0004-03", "generic_name": "Sterile Water Irrigant", "contact_info": "888-229-0001", "availability": "Available" | Current | Gastroenterology | 09/17/2026 | https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-sterile-water-irrigant-0338-0004-03/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Limited Availability | 1251 | [
"days_in_shortage"
] | Irrigant | Sterile Water Irrigant | baxter-healthcare-sterile-water-irrigant-0338-0004-04 | 04/28/2023 | Baxter Healthcare | 0338-0004-04 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Sterile%20Water%20Irrigant%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "04/28/2023", "package_ndc": "0338-0004-04", "generic_name": "Sterile Water Irrigant", "contact_info": "888-229-0001", "availability": "Limited Availability", "related_info": "Estimated recovery: September 2026" | Current | Gastroenterology | 09/17/2026 | https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-sterile-water-irrigant-0338-0004-04/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"related_info",
"shortage_reason",
"status",
"therapeutic_category",
"update_date"
] | Estimated recovery: September 2026 | Demand increase for the drug |
Available | 1689 | [
"days_in_shortage"
] | Injection | Dextrose Monohydrate 5% Injection | baxter-healthcare-dextrose-monohydrate-5-injection-0338-0017-02 | 02/14/2022 | Baxter Healthcare | 0338-0017-02 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "02/14/2022", "package_ndc": "0338-0017-02", "generic_name": "Dextrose Monohydrate 5% Injection", "contact_info": "888-229-0001", "availability": "Available" | Current | Endocrinology/Metabolism | 09/17/2026 | https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-dextrose-monohydrate-5-injection-0338-0017-02/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 1689 | [
"days_in_shortage"
] | Injection | Dextrose Monohydrate 5% Injection | baxter-healthcare-dextrose-monohydrate-5-injection-0338-0017-03 | 02/14/2022 | Baxter Healthcare | 0338-0017-03 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "02/14/2022", "package_ndc": "0338-0017-03", "generic_name": "Dextrose Monohydrate 5% Injection", "contact_info": "888-229-0001", "availability": "Available" | Current | Endocrinology/Metabolism | 09/17/2026 | https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-dextrose-monohydrate-5-injection-0338-0017-03/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 1689 | [
"days_in_shortage"
] | Injection | Dextrose Monohydrate 5% Injection | baxter-healthcare-dextrose-monohydrate-5-injection-0338-0017-10 | 02/14/2022 | Baxter Healthcare | 0338-0017-10 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "02/14/2022", "package_ndc": "0338-0017-10", "generic_name": "Dextrose Monohydrate 5% Injection", "contact_info": "888-229-0001", "availability": "Available" | Current | Endocrinology/Metabolism | 09/17/2026 | https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-dextrose-monohydrate-5-injection-0338-0017-10/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 1689 | [
"days_in_shortage"
] | Injection | Dextrose Monohydrate 5% Injection | baxter-healthcare-dextrose-monohydrate-5-injection-0338-0017-11 | 02/14/2022 | Baxter Healthcare | 0338-0017-11 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "02/14/2022", "package_ndc": "0338-0017-11", "generic_name": "Dextrose Monohydrate 5% Injection", "contact_info": "888-229-0001", "availability": "Available" | Current | Endocrinology/Metabolism | 09/17/2026 | https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-dextrose-monohydrate-5-injection-0338-0017-11/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 1689 | [
"days_in_shortage"
] | Injection | Dextrose Monohydrate 5% Injection | baxter-healthcare-dextrose-monohydrate-5-injection-0338-0017-18 | 02/14/2022 | Baxter Healthcare | 0338-0017-18 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "02/14/2022", "package_ndc": "0338-0017-18", "generic_name": "Dextrose Monohydrate 5% Injection", "contact_info": "888-229-0001", "availability": "Available" | Current | Endocrinology/Metabolism | 09/17/2026 | https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-dextrose-monohydrate-5-injection-0338-0017-18/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 1689 | [
"days_in_shortage"
] | Injection | Dextrose Monohydrate 5% Injection | baxter-healthcare-dextrose-monohydrate-5-injection-0338-0017-31 | 02/14/2022 | Baxter Healthcare | 0338-0017-31 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "02/14/2022", "package_ndc": "0338-0017-31", "generic_name": "Dextrose Monohydrate 5% Injection", "contact_info": "888-229-0001", "availability": "Available" | Current | Endocrinology/Metabolism | 09/17/2026 | https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-dextrose-monohydrate-5-injection-0338-0017-31/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
Available | 1689 | [
"days_in_shortage"
] | Injection | Dextrose Monohydrate 5% Injection | baxter-healthcare-dextrose-monohydrate-5-injection-0338-0017-38 | 02/14/2022 | Baxter Healthcare | 0338-0017-38 | https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000 | "initial_posting_date": "02/14/2022", "package_ndc": "0338-0017-38", "generic_name": "Dextrose Monohydrate 5% Injection", "contact_info": "888-229-0001", "availability": "Available" | Current | Endocrinology/Metabolism | 09/17/2026 | https://referencesource.org/drug-shortage-duration-tracker/baxter-healthcare-dextrose-monohydrate-5-injection-0338-0017-38/ | [
"availability",
"dosage_form",
"generic_name",
"initial_posting_date",
"manufacturer_name",
"package_ndc",
"status",
"therapeutic_category",
"update_date"
] | null | null |
End of preview. Expand in Data Studio
FDA drug shortage duration tracker
Canonical, always-current version: https://referencesource.org/drug-shortage-duration-tracker/ Machine-readable: https://referencesource.org/drug-shortage-duration-tracker/data.json — this mirror is a point-in-time copy.
- Last verified: 2026-09-30
- Stale after: 2026-10-03 (past this date, prefer the canonical copy — it re-verifies on a cadence this snapshot does not)
- Records: 1149
For every package FDA currently lists as in shortage: how long that shortage entry has been open (from openFDA's own initial_posting_date to today), what FDA says the package's supply is right now, and any recovery estimate FDA has given. What FDA itself publishes, checked directly on 2026-09-01 rather than assumed: the shortage list page (accessdata.fda.gov/scripts/drugshortages) shows which drugs are short and why and carries no date at all, while each per-drug detail page adds a single 'Date first posted' for the whole drug. Neither prints an elapsed duration, and neither gives the date per manufacturer. openFDA does — where several manufacturers report a shortage of the same drug, each carries its own posting date, and FDA's page shows only the earliest of them. Cross-checked across 30 drugs against those detail pages: 30 of 30 agreed, and in all 10 multi-manufacturer cases FDA's single date was exactly the earliest of ours. The underlying facts are FDA's own public-domain data; the duration is a computation over them that nobody publishes maintained, because it changes every day and hand-updating it was never worth the effort. A scheduled refetch of the same public API keeps it current for free. Read the duration next to availability, and do not read it alone: a shortage entry stays 'Current' until FDA resolves the whole shortage, so 63.8% of listed packages (746 of 1,169, measured 2026-09-01) are marked 'Available' even while their entry has been open for years — the median entry has been open 1,721 days and 1,118 of 1,169 have been open more than 1,000. Records cite a per-drug, per-manufacturer API query rather than a page offset, because openFDA's result ordering rotates daily and an offset URL stops containing its own record — see sources.txt. Source: https://api.fda.gov/drug/shortages.json (openFDA, no API key required at this volume). This is a monitored dataset, not a static page — stale_after_days is short and a build should re-run the fetch on a schedule rather than once.
Provenance — what every record carries
Every record carries source (the URL the value was read from) and
source_quote (a verbatim quote from that page stating it). A value you
cannot check against its page is indistinguishable from an invented one;
these can all be checked. Each record is also individually addressable on
the canonical site at its url.
Licence position
openFDA drug shortage data is a U.S. government work and is in the public domain. No source-licence question arises; each record still cites the specific API query and retrieval date it came from.
Facts are not copyrightable; what this dataset takes from each source is a fact plus a short attributed quote linking back to the page that states it.
Sources
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Methylprednisolone%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Clindamycin%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Mylan%20Specialty,%20a%20Viatris%20Company%22+AND+generic_name%3A%22Cromolyn%20Sodium%20Concentrate%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Ferring%22+AND+generic_name%3A%22Desmopressin%20Acetate%20Spray%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Furosemide%20Oral%20Solution%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sanofi-Aventis%20U.S.%20LLC%22+AND+generic_name%3A%22Rifampin%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Liraglutide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Rocuronium%20Bromide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Dopamine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Etomidate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Remifentanil%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Methotrexate%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Ifosfamide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Azacitidine%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Valproate%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Propranolol%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Cefotaxime%20Sodium%20Powder,%20for%20Solution%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Novo%20Nordisk,%20Inc.%22+AND+generic_name%3A%22Liraglutide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sandoz%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Amino%20Acid%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Sterile%20Water%20Irrigant%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Dextrose%20Monohydrate%2070%25%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Dextrose%20Monohydrate%2010%25%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22B.%20Braun%20Medical%20Inc.%22+AND+generic_name%3A%22Heparin%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Sterile%20Water%20Irrigant%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Dextrose%20Monohydrate%2010%25%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Ketorolac%20Tromethamine%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Heparin%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Amino%20Acid%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Dextrose%20Monohydrate%2070%25%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Dopamine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Metronidazole%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Dobutamine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Clindamycin%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Ifosfamide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Rising%20Pharma%20Holdings,%20Inc.%22+AND+generic_name%3A%22Flurazepam%20Hydrochloride%20Capsule%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Mylan%20Pharmaceuticals%20Inc.,%20a%20Viatris%20Company%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22SpecGx%20LLC%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22SpecGx%20LLC%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Midazolam%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Dobutamine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Dopamine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22InfoRLife%20SA%22+AND+generic_name%3A%22Metronidazole%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Pentostatin%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Heparin%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Meperidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Epinephrine%20Bitartrate,%20Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Hydromorphone%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Rocuronium%20Bromide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Atropine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride,%20Epinephrine%20Bitartrate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Morphine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Lorazepam%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Sodium%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Sufentanil%20Citrate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Ketorolac%20Tromethamine%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Sterile%20Water%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Sodium%20Bicarbonate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Furosemide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Dextrose%20Monohydrate%2050%25%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Etomidate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Fentanyl%20Citrate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Nephron%20Pharmaceuticals%20Corporation%22+AND+generic_name%3A%22Sterile%20Water%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22American%20Regent,%20Inc.%22+AND+generic_name%3A%22Atropine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Lannett%20Company,%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Lannett%20Company,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Noven%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Methylphenidate%20Film,%20Extended%20Release%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Padagis%20US%20LLC%22+AND+generic_name%3A%22Bacitracin%20Ophthalmic%20Ointment%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Hydroxocobalamin%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Hydromorphone%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Dexamethasone%20Sodium%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Promethazine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Lorazepam%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Bumetanide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Morphine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Fentanyl%20Citrate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Ketorolac%20Tromethamine%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Meperidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Midazolam%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Sterile%20Water%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Atropine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Sodium%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Hydromorphone%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Methotrexate%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Carboplatin%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Streptozocin%20Powder,%20For%20Solution%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sandoz%20Inc.%22+AND+generic_name%3A%22Rocuronium%20Bromide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sandoz%20Inc.%22+AND+generic_name%3A%22Clindamycin%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Jiangsu%20Hengrui%20Pharmaceuticals%20Co.,%20Ltd.%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Otsuka%20ICU%20Medical%20LLC%22+AND+generic_name%3A%22Amino%20Acid%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Otsuka%20ICU%20Medical%20LLC%22+AND+generic_name%3A%22Sterile%20Water%20Irrigant%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Otsuka%20ICU%20Medical%20LLC%22+AND+generic_name%3A%22Dextrose%20Monohydrate%2070%25%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Otsuka%20ICU%20Medical%20LLC%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Otsuka%20ICU%20Medical%20LLC%22+AND+generic_name%3A%22Dextrose%20Monohydrate%2010%25%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sunrise%20Pharmaceutical,%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Aurobindo%20Pharma%20USA%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Trigen%20Laboratories,%20LLC%22+AND+generic_name%3A%22Methylphenidate%20Hydrochloride%20Tablet,%20Extended%20Release%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Rising%20Pharma%20Holdings,%20Inc.%22+AND+generic_name%3A%22Cromolyn%20Sodium%20Concentrate%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Accord%20Healthcare%20Inc.%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Accord%20Healthcare%20Inc.%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Accord%20Healthcare%20Inc.%22+AND+generic_name%3A%22Methotrexate%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Accord%20Healthcare%20Inc.%22+AND+generic_name%3A%22Carboplatin%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Accord%20Healthcare%20Inc.%22+AND+generic_name%3A%22Azacitidine%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Accord%20Healthcare%20Inc.%22+AND+generic_name%3A%22Atropine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Accord%20Healthcare%20Inc.%22+AND+generic_name%3A%22Furosemide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Sufentanil%20Citrate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22SteriMax,%20Inc.%22+AND+generic_name%3A%22Cefotaxime%20Sodium%20Powder,%20for%20Solution%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22SteriMax,%20Inc.%22+AND+generic_name%3A%22Ifosfamide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Avet%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Furosemide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Avet%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Midazolam%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sagent%20Pharmaceuticals%22+AND+generic_name%3A%22Clindamycin%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Gland%20Pharma%20Limited%22+AND+generic_name%3A%22Furosemide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sagent%20Pharmaceuticals%22+AND+generic_name%3A%22Bumetanide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22InfoRLife%20SA%22+AND+generic_name%3A%22Ropivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Gland%20Pharma%20Limited%22+AND+generic_name%3A%22Midazolam%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sagent%20Pharmaceuticals%22+AND+generic_name%3A%22Rocuronium%20Bromide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Gland%20Pharma%20Limited%22+AND+generic_name%3A%22Ketorolac%20Tromethamine%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sagent%20Pharmaceuticals%22+AND+generic_name%3A%22Ketorolac%20Tromethamine%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sagent%20Pharmaceuticals%22+AND+generic_name%3A%22Methylprednisolone%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Aspiro%20Pharma%20Limited%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Furosemide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22XGen%20Pharmaceuticals%20DJB,%20Inc.%22+AND+generic_name%3A%22Rocuronium%20Bromide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22XGen%20Pharmaceuticals%20DJB,%20Inc.%22+AND+generic_name%3A%22Promethazine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Par%20Health,%20USA%20LLC%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Par%20Health,%20USA%20LLC%22+AND+generic_name%3A%22Methylprednisolone%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Micro%20Labs%20LTD%22+AND+generic_name%3A%22Cromolyn%20Sodium%20Concentrate%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Epic%20Pharma,%20LLC%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Epic%20Pharma,%20LLC%22+AND+generic_name%3A%22Rifampin%20Capsule%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Rhodes%20Pharmaceuticals%20L.P.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Baxter%20Healthcare%22+AND+generic_name%3A%22Rocuronium%20Bromide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Caplin%20Steriles,%20Ltd.%22+AND+generic_name%3A%22Ropivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Prinston%20Pharmaceutical,%20Inc.%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Solco%20Healthcare%20US,%20LLC%22+AND+generic_name%3A%22Quinapril%20Hydrochloride%20Tablet%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Solco%20Healthcare%20US,%20LLC%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Dr.%20Reddy%27s%20Laboratories,%20Inc.%22+AND+generic_name%3A%22Azacitidine%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Gland%20Pharma%20Limited%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22HQ%20Specialty%20Pharma%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22WG%20Critical%20Care%22+AND+generic_name%3A%22Midazolam%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sun%20Pharmaceutical%20Industries,%20Inc.%22+AND+generic_name%3A%22Technetium%20TC-99M%20Pyrophosphate%20Kit%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Gland%20Pharma%20Limited%22+AND+generic_name%3A%22Metronidazole%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Alvogen%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Alvogen%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fera%20Pharmaceuticals%22+AND+generic_name%3A%22Echothiophate%20Iodide%20Ophthalmic%20Solution%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Janssen%20Pharmaceuticals%22+AND+generic_name%3A%22Methylphenidate%20Hydrochloride%20Tablet,%20Extended%20Release%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22BTG%20International%20Inc.%22+AND+generic_name%3A%22Hydroxocobalamin%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Exela%20Pharma%20Sciences,%20LLC%22+AND+generic_name%3A%22Sodium%20Bicarbonate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Azurity%20Pharmaceuticals,%20Inc%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Gland%20Pharma%20Limited%22+AND+generic_name%3A%22Carboplatin%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Ropivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Etomidate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Rocuronium%20Bromide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Dexamethasone%20Sodium%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Methylprednisolone%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Furosemide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Carboplatin%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Eugia%20US%20LLC%22+AND+generic_name%3A%22Azacitidine%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sun%20Pharmaceutical%20Industries,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sun%20Pharmaceutical%20Industries,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Tablet,%20Chewable%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Sun%20Pharmaceutical%20Industries,%20Inc.%22+AND+generic_name%3A%22Methylphenidate%20Hydrochloride%20Tablet,%20Extended%20Release%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Medexus%22+AND+generic_name%3A%22Triamcinolone%20Hexacetonide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Takeda%20Pharmaceuticals%20USA%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Takeda%20Pharmaceuticals%20USA%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Tablet,%20Chewable%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Bristol%20Myers%20Squibb%20Co.%22+AND+generic_name%3A%22Azacitidine%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Aurobindo%20Pharma%20USA%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Apotex%20Corp.%22+AND+generic_name%3A%22Desmopressin%20Acetate%20Spray%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Apotex%20Corp.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teyro%20Labs%22+AND+generic_name%3A%22Carboplatin%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Pfizer%20Inc.%22+AND+generic_name%3A%22Penicillin%20G%20Benzathine%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Cheplapharm%20Arzneimittel%20GmbH%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Methotrexate%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hospira,%20Inc.,%20a%20Pfizer%20Company%22+AND+generic_name%3A%22Carboplatin%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Methylphenidate%20Hydrochloride%20Tablet,%20Extended%20Release%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Chartwell%20Molecular%20Holdings%20LLC%22+AND+generic_name%3A%22Quinapril%20Hydrochloride%20Tablet%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Chartwell%20Molecular%20Holdings%20LLC%22+AND+generic_name%3A%22Quinapril/Hydrochlorothiazide%20Tablet%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Chartwell%20Molecular%20Holdings%20LLC%22+AND+generic_name%3A%22Flurazepam%20Hydrochloride%20Capsule%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Lannett%20Company,%20Inc.%22+AND+generic_name%3A%22Methylphenidate%20Hydrochloride%20Tablet,%20Extended%20Release%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Alembic%20Pharmaceuticals%22+AND+generic_name%3A%22Ketorolac%20Tromethamine%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Sodium%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Sodium%20Bicarbonate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Methotrexate%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Ifosfamide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Ketorolac%20Tromethamine%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Dexamethasone%20Sodium%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Carboplatin%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Sterile%20Water%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Furosemide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Ropivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Rifampin%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Midazolam%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Rocuronium%20Bromide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Morphine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride,%20Epinephrine%20Bitartrate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Epinephrine%20Bitartrate,%20Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Valproate%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Heparin%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Atropine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Propranolol%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Remifentanil%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Azacitidine%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Fentanyl%20Citrate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Dextrose%20Monohydrate%2010%25%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Hydromorphone%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Medefil,%20Inc.%22+AND+generic_name%3A%22Sterile%20Water%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Medefil,%20Inc.%22+AND+generic_name%3A%22Atropine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Elite%20Laboratories,%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Elite%20Laboratories,%20Inc.%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Amneal%20Pharmaceuticals%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Capsule%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Lorazepam%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Caplin%20Steriles,%20Ltd.%22+AND+generic_name%3A%22Etomidate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Dextrose%20Monohydrate%205%25%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Fresenius%20Kabi%20USA,%20LLC%22+AND+generic_name%3A%22Bumetanide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Spectra%20Medical%20Devices,%20LLC%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Aurobindo%20Pharma%20USA%22+AND+generic_name%3A%22Quinapril/Hydrochlorothiazide%20Tablet%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Aurobindo%20Pharma%20USA%22+AND+generic_name%3A%22Quinapril%20Hydrochloride%20Tablet%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Cumberland%20Pharmaceuticals%20Inc.%22+AND+generic_name%3A%22Conivaptan%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Piramal%20Critical%20Care%20Inc.%22+AND+generic_name%3A%22Morphine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Piramal%20Critical%20Care%20Inc.%22+AND+generic_name%3A%22Rocuronium%20Bromide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Mylan%20Institutional,%20a%20Viatris%20Company%22+AND+generic_name%3A%22Rocuronium%20Bromide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Mylan%20Institutional,%20a%20Viatris%20Company%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Mylan%20Institutional,%20a%20Viatris%20Company%22+AND+generic_name%3A%22Dexamethasone%20Sodium%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Mylan%20Institutional,%20a%20Viatris%20Company%22+AND+generic_name%3A%22Rifampin%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Mylan%20Institutional,%20a%20Viatris%20Company%22+AND+generic_name%3A%22Etomidate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Teva%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Azacitidine%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Vertical%20Pharmaceuticals,%20LLC%22+AND+generic_name%3A%22Methylphenidate%20Hydrochloride%20Tablet,%20Extended%20Release%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22ESTEVE%20PHARMACEUTICALS,%20S.A.%22+AND+generic_name%3A%22Streptozocin%20Powder,%20For%20Solution%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Lupin%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Quinapril%20Hydrochloride%20Tablet%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Lupin%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Rifampin%20Capsule%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Ailex%20Pharmaceuticals%22+AND+generic_name%3A%22Cromolyn%20Sodium%20Concentrate%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Curium%20US%20LLC%22+AND+generic_name%3A%22Technetium%20TC-99M%20Pyrophosphate%20Kit%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Granules%20Pharmaceuticals%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Somerset%20Therapeutics,%20LLC%22+AND+generic_name%3A%22Dexamethasone%20Sodium%20Phosphate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Somerset%20Therapeutics,%20LLC%22+AND+generic_name%3A%22Sodium%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Somerset%20Therapeutics,%20LLC%22+AND+generic_name%3A%22Ropivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Somerset%20Therapeutics,%20LLC%22+AND+generic_name%3A%22Atropine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Somerset%20Therapeutics,%20LLC%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Somerset%20Therapeutics,%20LLC%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Amneal%20Pharmaceuticals%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Amneal%20Pharmaceuticals%22+AND+generic_name%3A%22Methylprednisolone%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hainan%20Poly%20Pharm.%20Co.,%20Ltd.%22+AND+generic_name%3A%22Dobutamine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22EDW%20Pharma,%20Inc.%20(formerly%20Italfarmaco%20Pharma,%20Inc.)%22+AND+generic_name%3A%22Riluzole%20Oral%20Suspension%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Meitheal%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Azacitidine%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Meitheal%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Furosemide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Meitheal%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Meitheal%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Liraglutide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Meitheal%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Rocuronium%20Bromide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Kindos%20Pharmaceuticals%20Co.%20Ltd.%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Milla%20Pharmaceuticals%22+AND+generic_name%3A%22Sodium%20Acetate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Mylan%20Institutional,%20a%20Viatris%20Company%22+AND+generic_name%3A%22Remifentanil%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22MSN%20Laboratories%20Private%20Limited%22+AND+generic_name%3A%22Bumetanide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Novadoz%20Pharmaceuticals%20LLC%22+AND+generic_name%3A%22Lisdexamfetamine%20Dimesylate%20Tablet,%20Chewable%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Gland%20Pharma%20Limited%22+AND+generic_name%3A%22Etomidate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22ONESOURCE%20SPECIALTY%20PTE%20LTD%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Lifsa%20Drugs%20LLC%22+AND+generic_name%3A%22Isocarboxazid%20Tablet%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Armas%20Pharmaceuticals%20Inc%22+AND+generic_name%3A%22Azacitidine%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Oryza%20Pharmaceuticals%20Inc.%22+AND+generic_name%3A%22Amphetamine%20Aspartate%20Monohydrate,%20Amphetamine%20Sulfate,%20Dextroamphetamine%20Saccharate,%20Dextroamphetamine%20Sulfate%20Tablet%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Rubicon%20Research%20Private%20Limited%22+AND+generic_name%3A%22Clonazepam%20Tablet%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Huons%20Co.,%20Ltd.%20(South%20Korea)%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Huons%20Co.,%20Ltd%22+AND+generic_name%3A%22Bupivacaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Amphastar%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Morphine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Amphastar%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Dextrose%20Monohydrate%2050%25%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Amphastar%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Atropine%20Sulfate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Amphastar%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Sodium%20Bicarbonate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Amphastar%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Amphastar%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Lorazepam%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Long%20Grove%20Pharmaceuticals%20LLC%22+AND+generic_name%3A%22Sodium%20Bicarbonate%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Mullan%20Pharmaceutical%20Inc.%22+AND+generic_name%3A%22Bumetanide%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Jiangsu%20Hengrui%20Pharmaceuticals%20Co.%20(US%20Agent%20eVenus%20Pharmaceutical%20Laboratories,%20Inc.)%22+AND+generic_name%3A%22Dexmedetomidine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Anthea%20Pharma%22+AND+generic_name%3A%22Lidocaine%20Hydrochloride%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Avyxa%20Pharma,%20LLC%22+AND+generic_name%3A%22Carboplatin%20Injection%22+AND+status%3A%22Current%22&limit=1000
- https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Laboratorios%20Atral%22+AND+generic_name%3A%22Penicillin%20G%20Benzathine%20Injection%22+AND+status%3A%22Current%22&limit=1000
Fields
See any record in data/records.jsonl — field names are self-describing,
and the canonical page for each record renders them with labels:
https://referencesource.org/drug-shortage-duration-tracker/
- Downloads last month
- 63